Global Cell Signaling Market Trends and Industry Analysis Report 2019

The Cell Signaling Market is expected to reach $ 3.51 Billion by 2022, at a CAGR of 6.8%

(EMAILWIRE.COM, January 17, 2019 ) According to the new market research report “Cell Signaling Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) — Global Forecast to 2022”, published by MarketsandMarkets™.

Don’t miss out on business opportunities in Cell Signaling Market

Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=80206120

Growth in the Cell Signaling Market is driven by the rising incidence of chronic diseases, availability of funding for cell-based research, technological advancements in cell-based research instruments, and the growth of the life science and biopharmaceutical industries.

This report segments the Cell Signaling Market on the basis of product, pathway, signaling type, technology, application, and region. Based on product, the market is segmented into consumables and instruments. The cell signaling consumables segment is estimated to account for the largest share of the Cell Signaling Market in 2017. The increasing number of cell signaling research activities and rising incidence of chronic diseases are some of the major factors contributing to the segments large market share.

Browse and in-depth TOC on “ Cell Signaling Market “

157 — Tables

76 — Figures

212 — Pages

By pathway, the Cell Signaling Market is segmented into AMP-activated protein kinase (AMPK), Akt, ErbB/HER, Hedgehog (Hh), NF-êB, Janus kinase and signal transducer and activator of transcription (JAK/STAT), Notch, and other signaling pathways. The Akt pathway segment is estimated to account for the largest share of the Cell Signaling Market in 2017.

Download PDF:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80206120

Based on application, the market is segmented into research applications (cancer research, immunology research, stem cells research, and other research applications) and medical applications. The research applications segment is estimated to account for the largest share of the Cell Signaling Market in 2017

The key players in the Cell Signaling Market:

Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.)